جست‌وجوی استاد و پژوهشگر

• Thrombosis
• Hematology
• Immunology
• +۳ مورد دیگر

Dr. Jose Perdomo is a Research Fellow at the Central Clinical School, Sydney Medical School, within the Faculty of Medicine and Health at the University of Sydney. He is based at the Charles Perkins Centre, where his research focuses on endothelial damage, immune complex-driven thrombosis, and platelet formation mechanisms. His work employs techniques such as flow cytometry, microfluidics, and intravital microscopy. Dr. Perdomo holds a PhD from the University of Sydney’s School of Molecular and Microbial Biosciences and received a Vice-Chancellor’s Fellowship. His research has led to two international patents and recognition, including 1st prize in the 2020 China Shenzhen Innovation Competition. His studies explore targeted inhibitors to prevent immune complex formation and thrombosis, with applications in cardiovascular health. His research interests include the interplay between white blood cells, endothelial cells, and platelets, with a focus on desialylation, apoptosis, and NETosis in immune thrombocytopenia. He has contributed to understanding vaccine-induced immune thrombocytopenia and thrombotic complications post-myocardial infarction. His findings have been featured in Nature Communications , Blood Advances , and other high-impact journals. Awards: 1st prize in China Shenzhen Innovation Competition (2020). Labs/Teams: Charles Perkins Centre, University of Sydney. Grants: Vice-Chancellor’s Fellowship (University of Sydney). Media Contributions: Insights into AstraZeneca vaccine-related blood clots featured in The Guardian , SMH , and ABC News.

• Critical Care Medicine
• Immunology
• Trauma Surgery
• +۵ مورد دیگر

Vanessa Nomellini, MD, PhD is an Associate Professor in the Division of Burn, Trauma, Acute and Critical Care Surgery at UT Southwestern Medical Center. She joined UT Southwestern in 2023 as the director of research for her division and leader in the Critical Care Outcomes Research Translation (CORT) group. Education: Dr. Nomellini earned her MD and PhD in Cellular and Molecular Biochemistry from Loyola University. She completed her general surgery residency at the University of Wisconsin and Surgical Critical Care fellowship at the University of Pennsylvania. Research Interests: Her work focuses on immune dysfunction in critically ill patients, particularly sepsis and trauma-induced immunosuppression. She leads studies on immune recovery mechanisms and develops the ICU Recovery Program for long-term patient management. Her NIH-funded research (R35 NIGMS) investigates immune suppression through both animal models and human observational studies. Publications Trends: Her recent work emphasizes sepsis pathophysiology, coagulopathy management, and clinical improvements in critical care. Key areas include immunomodulatory therapies, biomarker utility, and optimizing ICU protocols. Scientific Awards: Recipient of NIGMS R35 grant (2019-current) Advising & Grants: Leads a multi-institutional research team and holds leadership roles in CORT. Her grants focus on translational immunology and critical care outcomes. Labs & Teams: Directs research at UT Southwestern's Critical Care Division, collaborating with Drs. Levi and Carlson in CORT initiatives.

Jiayi Tongمشاهده پروفایل

استادیار

• Biostatistics
• Real-World Data Analysis
• Meta-Analysis
• +۶ مورد دیگر

Jiayi (Jessie) Tong, PhD is an Assistant Professor in the Department of Biostatistics at Johns Hopkins University, with joint appointments in the Bloomberg School of Public Health and School of Medicine. She received her PhD from the University of Pennsylvania in 2024 and has rapidly established herself as a leading researcher in biostatistical methods for real-world data analysis. Dr. Tong's research program focuses on clinical evidence generation and evidence synthesis with real-world data (RWD). Her work spans three main areas: clinical evidence generation using data from distributed research networks, surrogate-assisted semi-supervised learning methods, and systematic reviews and meta-analyses. She has developed innovative statistical methodologies for analyzing electronic health records across multiple institutions while preserving patient privacy through distributed computing approaches. Her research has significant implications for improving evidence generation in healthcare, particularly for rare conditions and emerging health threats where traditional clinical trials may be impractical. Analysis of Dr. Tong's publication record reveals a strong emphasis on methodological innovation in biostatistics, particularly in the areas of federated learning, meta-analysis, and electronic health record analysis. Her work frequently addresses challenges in multi-site collaborative studies, developing one-shot algorithms that enable analysis without sharing patient-level data. Much of her recent research has focused on applications to SARS-CoV-2 infection and its sequelae, demonstrating the practical utility of her methodological contributions to pressing public health challenges. Dr. Tong has demonstrated exceptional productivity since completing her PhD in 2024, with numerous high-impact publications in top biostatistics and medical journals. Her work has been recognized through mentions on various platforms including Mendeley readership and blog coverage. As a new faculty member, Dr. Tong is actively building her research program and mentoring the next generation of biostatisticians. Her expertise in distributed analysis of healthcare data positions her at the forefront of methodological developments needed to address contemporary challenges in evidence generation.

• General Surgery
• Pediatrics
• Surgical Critical Care
• +۳ مورد دیگر

John F. Bilello is a Clinical Professor in the Department of Surgery at the University of California, San Francisco (UCSF) Fresno and Chief of Pediatric Trauma at Community Regional Medical Center (CRMC). He received his bachelor’s degree in Natural Sciences from Johns Hopkins University (1981) and his MD from New York University School of Medicine (1985). His clinical expertise spans General Surgery, Pediatrics, and Surgical Critical Care, with over 27 years of teaching experience at UCSF Fresno and Walter Reed Army Medical Center. Education: Johns Hopkins University (BA, Natural Sciences), New York University School of Medicine (MD) Training: Internships and residencies in Pediatrics and General Surgery at Walter Reed Army Medical Center, Fellowship in Trauma/Critical Care at UCSF Fresno Dr. Bilello’s research focuses on trauma resuscitation, critical care outcomes, and post-trauma complications. He has published extensively on topics such as shock assessment, pulmonary contusion management, and vascular trauma interventions, with recent work emphasizing evidence-based practices in trauma care. His collaborations with colleagues like James Davis and Krista Kaups highlight interdisciplinary efforts in trauma surgery. He has received numerous scientific awards, including military honors (National Defense Medal, Kuwait Liberation Medals) and clinical recognition (CRMC Care Hero Award, UCSF Fresno Borba Housestaff Research Award). Dr. Bilello also serves as a course director for the Advanced Surgical Skills for Exposure in Trauma (ASSET) program at CRMC.

Divyaswathi Citla Sridharمشاهده پروفایل

استادیار

• Hematology
• Oncology
• Bleeding Disorders
• +۷ مورد دیگر

Dr. Divyaswathi Citla Sridhar is an Assistant Professor of Pediatric Hematology/Oncology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine, Department of Pediatrics. Her research focuses on bleeding disorders such as hemophilia, von Willebrand disease, and Glanzmann thrombasthenia, with a particular emphasis on bone health, menstrual bleeding management, sickle cell disease, and thrombosis. She also investigates the intersection of hematology with mental health and healthcare access, particularly in underserved populations. Her studies employ large national database analyses and cohort studies to explore outcomes, risk factors, and healthcare utilization patterns. She has contributed to understanding vitamin D therapy in sickle cell disease, the burden of rare platelet disorders, and palliative care trends in malignant neoplasms. Her work bridges clinical practice and public health, addressing disparities in hemophilia treatment access and improving diagnostic approaches through case studies and systematic reviews. Key areas of expertise include bone health in bleeding disorders, reproductive health needs in patients with bleeding disorders, and the impact of anticoagulants on menstrual bleeding. Her research also addresses emerging issues such as thrombotic microangiopathies and fungal infections in immunocompromised pediatric patients.

• Hematopathology
• Anatomic and Clinical Pathology
• Neoplasia
• +۷ مورد دیگر

Lekidelu Taddesse-Heath, MD, is an Associate Professor and Director of Hematopathology in the Department of Pathology at the College of Medicine, Howard University. She specializes in Anatomic and Clinical Pathology with subspecialty expertise in Hematopathology. Education: MD in Medicine – Addis Ababa University Faculty of Medicine, Ethiopia (1988) Anatomic and Clinical Pathology Residency – Howard University Hospital, Washington, DC (1996) Post Doctoral Fellowship – National Institutes of Health, Bethesda, MD (1999) Hematopathology Fellowship – National Institutes of Health, Bethesda, MD (2002) Her research and teaching interests include hematopathology, neoplasia, coagulation disorders, and general principles of cell injury and inflammation. She actively contributes to medical education as a facilitator in pathology small group discussions. Her scholarly work focuses on rare tumors, lymphomas, and multi-system malignancies, with a particular interest in disease presentation in African American populations. The recent publications reflect a strong focus on rare and complex neoplastic conditions across multiple organ systems, including hematologic malignancies, uterine tumors, and head and neck pathology. These studies often involve case reports and literature reviews, emphasizing diagnostic challenges and clinicopathologic correlations. No scientific awards were mentioned in the provided text. Dr. Taddesse-Heath mentors trainees through collaborative research, though specific details about formal student advising or grant-funded research are not available. She plays a leadership role as Director of Hematopathology, contributing to diagnostic services and academic training in pathology. There is no mention of specific laboratories or research teams in the provided information.

Alexander S. Nivenمشاهده پروفایل

استاد مدعو

• Medical Education
• Simulation-Based Learning
• Critical Care Outcomes
• +۳ مورد دیگر

Dr. Alexander S. Niven is an Adjunct Professor at Uniformed Services University of the Health Sciences and a senior medical staff member at Mayo Clinic College of Medicine and Science , specializing in Pulmonary and Critical Care Medicine . He has held leadership roles in education, simulation-based training, and clinical guideline development since the early 2000s. Education: MD (Tufts University School of Medicine, 1995), BS (Georgetown University, 1991), Pulmonary/Critical Care Fellowship (Walter Reed Army Medical Center, 2001). Research Interests: Medical education (simulation, active learning), critical care outcomes, difficult airway management, and dyspnea. His work bridges clinical practice and educational innovation, particularly in critical care settings. Publications (Recent Trends): Focused on renal replacement therapy timing, aerosol generation during diagnostics, and equity in pulmonary diagnostics, reflecting his dual expertise in clinical research and medical education. Scientific Awards: 2025 Endowment for Education Research Award (Mayo Clinic) 2023 Society of Critical Care Medicine Silver Snapshot Award 2022 CHEST Edward C. Rosenow III, M.D., Master Teacher Lecturer 2018 Laureate Award (American College of Physicians Army Chapter) Leadership: Chair of multiple committees at CHEST, Mayo Clinic, and military medical institutions. Coordinated simulation centers and developed guidelines for airway management.

Adam C. Alderمشاهده پروفایل

استادیار

• Pediatric Surgery
• Surgical Oncology
• Minimally Invasive Surgery
• +۷ مورد دیگر

Adam C. Alder, MD is a pediatric surgeon holding academic and leadership roles at the University of Texas Southwestern Medical Center (UTSW) and Children's Health. He serves as Chief of Pediatric Surgery at Children's Health - Plano and Director of the internationally recognized Center for Pectus and Chest Wall Anomalies, a collaboration between UTSW and Children's Health. His clinical expertise spans pediatric and neonatal surgery, including thoracic and general surgery, surgical oncology, minimally invasive/robotic approaches, and chest wall anomaly correction. He leads a team of pediatric surgeons in North Texas and actively develops clinical research initiatives through the Center for Advanced Research in Surgery. Education: Tulane University School of Medicine (2002), General Surgery Residency at UTSW/Parkland Hospital, Pediatric Surgery Fellowship at Children's Medical Center/UTSW. He completed the NIH-funded CTSA Clinical Scholars Program and holds an academic appointment as Assistant Professor in the Department of Surgery's Division of Pediatric Surgery. Research focuses on pediatric appendicitis etiology, cardiac MRI applications in pectus excavatum, and clinical advancements in chest wall anomalies. Notable contributions include pioneering the Dynamic Compression Bracing System for pectus patients and advancing evidence-based trauma care through the ATOMAC consortium. Professional activities include leadership roles in surgical societies and grants from UTSW's Department of Surgery. His surgical practice spans Dallas and Plano campuses, emphasizing both clinical innovation and compassionate patient care.

• Pulmonary Hypertension
• Angioplasty
• Chronic Thromboembolic Pulmonary Hypertension
• +۲ مورد دیگر

Matīss Šablinskis is a Lecturer at the Department of Internal Diseases, University of Latvia. His work focuses on pulmonary hypertension, interventional cardiology, and internal medicine, with a particular emphasis on chronic thromboembolic pulmonary hypertension (CTEPH) and balloon pulmonary angioplasty. Over his career, he has contributed to 17 research outputs and collaborated on clinical trials at Pauls Stradiņš Clinical University Hospital. Research Trends: Šablinskis's publications span Chronic thromboembolic pulmonary hypertension (CTEPH) Interventional therapies like balloon pulmonary angioplasty Functional capacity assessment in right ventricular failure Physiotherapy applications for pulmonary arterial hypertension Hematologic and hemodynamic correlations in CTEPH Key Collaborations: Active partnerships include institutions in Poland (Kurzyna M.), Latvia (Skride A., Lejnieks A.), and researchers in thromboembolic disorders. His work aligns with UN Sustainable Development Goals 3.2 (Clinical Medicine).

• Veterinary Pathology
• Public Health
• Disease Investigation
• +۳ مورد دیگر

Dr. Angie Rupp is a Senior Veterinary Clinician affiliated with the University of Glasgow's School of Veterinary Medicine. She specializes in Veterinary Pathology, Public Health, and Disease Investigation, with a focus on neuroimmunological disorders in animals. Role: Senior Veterinary Clinician Institution: University of Glasgow School: School of Veterinary Medicine Her research explores autoimmune peripheral neuropathies, lysosomal storage disorders, and mitochondrial diseases in veterinary contexts. She investigates biomarkers like anti-ganglioside antibodies and develops animal models for human neurological conditions such as Guillain-Barré Syndrome. Recent publications highlight her work on feline and canine neurological disorders, metabolic encephalopathies, and surgical interventions in equine medicine. Her studies often integrate genetic analysis, imaging techniques, and translational research approaches. Scientific awards include grants from the Petplan Charitable Trust (2021) Petsavers (2017-2019) for research into neurological biomarkers and disease mechanisms.

Sharonlin Bhardwajمشاهده پروفایل

استادیار بالینی

• Breast Cancer
• Medical Oncology
• Hematology
• +۶ مورد دیگر

Sharonlin Bhardwaj, M.D., is an Assistant Clinical Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope (2023–present). She previously held the same rank in the Hospital Medicine department at New York University (2018–2020). Her clinical expertise focuses on Breast Cancer , with a multidisciplinary approach to patient care. Education: B.S. in Human Biology and Science Education, University of California San Diego (2006–2010) M.D., St. George’s University School of Medicine (2011–2015) Fellowship in Hematology and Oncology, Olive View-UCLA Medical Center (2020–2023) Residency in Internal Medicine, Maimonides Medical Center (2015–2018) Her research spans cancer therapeutics , hematological complications , and infectious disease interactions in oncology. Key areas include anticoagulant therapy , paraneoplastic syndromes , and metastatic cancer complications . Recent publications highlight collaborations in hematology-oncology , neurological effects of cancer , and infectious disease co-morbidities . Dr. Bhardwaj’s clinical work emphasizes patient-centered care and multidisciplinary collaboration, particularly in breast cancer treatment . She has presented at international conferences, including the International Society of Thrombosis and Hemostasis and the American Thoracic Society Annual Conference .

• Chronic lymphocytic leukemia
• Hairy cell leukemia
• Prolymphocytic leukemia
• +۷ مورد دیگر

Dr. Clive S. Zent is a Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He specializes in chronic lymphocytic leukemia (CLL), hairy cell leukemia, prolymphocytic leukemia, lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia), and large granular lymphocytic leukemia. As part of the University of Rochester Medical Faculty Group and Accountable Health Partners, Dr. Zent provides expert care for blood cancers with a focus on precision diagnosis and targeted therapy. Dr. Zent's educational background includes: MBBCH from University of Witwatersrand (South Africa) in 1983 (Degree with Distinction) Internship in Internal Medicine at Coronation Hospital (South Africa) in 1984 Residency in Internal Medicine at Groote Schuur Hospital (South Africa) from 1987-1991 Fellowship in Hematology & Oncology at University of Chicago Medical Center from 1993-1996 Residency in Internal Medicine at University of Arkansas College of Medicine in 1996-1997 Dr. Zent's research has significantly advanced our understanding of therapeutic monoclonal antibodies for CLL, molecular prognostic markers, diagnosis of related diseases, and management of autoimmune cytopenias and second malignancies. His work spans immunotherapy mechanisms, antibody-mediated phagocytosis, vaccine responses in immunocompromised patients, and cardiotoxicity from novel lymphoma treatments. He has been instrumental in developing international patient registries for hairy cell leukemia and establishing consensus guidelines. His recent publications reveal a strong focus on targeted therapies for CLL and hairy cell leukemia, including BTK inhibitors, PI3K inhibitors, and novel combination regimens. There's significant attention to treatment-related complications like atrial fibrillation and infection risks, healthcare disparities among different patient populations, and increasingly incorporates patient-centered outcomes and quality of life considerations. Dr. Zent has received several prestigious awards: Hematology Teacher of the Year (2023-2024) Teacher of the Year in Hematology (2008) Kaminer Fellowship (Travel Award) (1995) Degree with Distinction from University of Witwatersrand (1983) As a dedicated clinician-educator, Dr. Zent has mentored numerous medical students, residents, and fellows. Patient comments consistently highlight his exceptional communication skills, thorough explanations, and compassionate approach. He actively participates in multicenter clinical trials and collaborative research initiatives focused on improving outcomes for patients with leukemias and lymphomas. Dr. Zent maintains an active clinical practice at the Wilmot Cancer Center at Strong Memorial Hospital, where he continues to investigate novel therapeutic approaches for chronic lymphocytic leukemia and related disorders, with particular interest in optimizing treatment sequencing and managing treatment-related complications.

Robert Regeمشاهده پروفایل

استاد

• Gastrointestinal Surgery
• Laparoscopic Surgery
• Gallstone Pathogenesis
• +۳ مورد دیگر

Robert Rege is a distinguished academic surgeon and Professor at the University of Texas Southwestern Medical Center, where he serves as Chairman of the Department of Surgery. He holds the Hall and Mary Lucille Shannon Distinguished Professorship. With a career spanning over four decades, Dr. Rege has held prominent roles, including Chief of Surgical Services at the VA Chicago Medical Center and Tenured Professor of Surgery at Northwestern University. His expertise lies in gastrointestinal surgery, laparoscopic techniques, and gallstone pathogenesis. He pioneered advanced minimally invasive procedures, such as laparoscopic living donor nephrectomy in the Midwest. He has led a long-term NIH-funded research program studying gallstone formation. Dr. Rege is also a pioneer in surgical education, emphasizing competency-based training and the use of simulation for skill development. Education: BS in Chemical Engineering, Lehigh University (1971) MD, The Milton S. Hershey Medical School, Pennsylvania State University (1975) Research Interests: Dr. Rege’s work focuses on minimally invasive surgery, gallstone pathogenesis, and surgical education. He has contributed to advancements in laparoscopic techniques, including hernia repair, fundoplication, and splenectomy. His research on inflammatory mechanisms in gallbladder disease has advanced understanding of cholesterol crystallization and mucosal responses. He advocates for standardized training programs to enhance surgical competence. Publications: Over 60 peer-reviewed articles span surgical techniques, gallstone research, and educational methodologies. Recent work addresses intra-abdominal fat assessment, VA academic affiliations, and resident training innovations. His articles emphasize translating research into clinical practice, such as optimizing laparoscopic skill acquisition and evaluating competency metrics. Awards: The Hall and Mary Lucille Shannon Distinguished Professorship (2001) recognizes his contributions to academic surgery. His leadership in surgical training and innovation has earned institutional and national acclaim. Grants & Labs: His NIH-funded gallstone research program (since 1983) explores biliary calcium secretion and inflammatory pathways. He collaborates with the Division of Transplantation Surgery and VA Medical Centers, advancing translational research and clinical care.

Julian Joseph Boscoمشاهده پروفایل

عضو هیئت علمی

• Clinical Immunology
• Allergy
• Immunopathology
• +۷ مورد دیگر

Dr. Julian Joseph Bosco is an Adjunct Senior Lecturer in the Faculty of Medicine at Monash University and holds clinical appointments at Alfred Health, Alfred Pathology, and Epworth Allergy Specialists. His expertise lies in Clinical Immunology, Allergy, and Immunopathology, with a focus on autoimmune diseases, immunodeficiency, and B-cell dysfunction. Education: Bachelor of Medicine and Bachelor of Surgery with Honours, University of New South Wales (2002) PhD on immunoregulatory properties of CD52, Walter and Eliza Hall Institute of Medical Research Fellowship, Royal Australasian College of Physicians Fellowship, Royal College of Pathologists of Australasia His research interests include: Inborn errors of immunity Immune responses in high-risk populations (e.g., post-splenectomy, immunocompromised) Autoantibody-associated autoimmune diseases Effects of biologic therapies on immune function SARS-CoV-2 immunity in immunodeficient patients Recent publications highlight his work on B-cell immunology, vaccine responses after splenic injury, and complications of immunomodulatory drugs. His studies often involve translational research with clinical applications in immunodeficiency and allergic diseases. Scientific Contributions: Active participation in major research projects including PROPHECY (immune responses to SARS-CoV-2) Development of assays for genetic variants in inborn errors of immunity Establishment of the Jeffrey Modell Center in Melbourne for primary immunodeficiency Dr. Bosco serves as a Chief or Associate Investigator on multiple funded studies and collaborates with leading research institutes including Murdoch Children's Research Institute and Burnet Institute. He contributes to advancing clinical guidelines and public health strategies related to immune disorders. Laboratory and Research Teams: Member of the Clinical Immunology and Allergy team at Alfred Hospital Collaborator in the van Zelm Laboratory (Monash University) focusing on B-cell development and immunodeficiency Part of multidisciplinary teams investigating post-traumatic immunity and vaccine efficacy

• Trauma Surgery
• Acute Care Surgery
• Domestic Violence
• +۳ مورد دیگر

James Davis, MD, FACS is a Professor of Clinical Surgery at the University of California, San Francisco (UCSF) School of Medicine and serves as the Chief of Trauma at Community Regional Medical Center. He holds the Steven N. Parks Endowed Chair of Surgery at UCSF Fresno and directs the Acute Care Surgery Fellowship Program , which was the first of its kind in California. His career spans multiple leadership roles in trauma systems development, including chairing the Central California Regional Trauma Coordinating Committee and national initiatives through the American College of Surgeons . University of California San Diego, BA Biology (1977) University of Iowa School of Medicine, MD (1981) Residency: Maricopa Medical Center (1986) Fellowship: UC San Diego Trauma (1987) Dr. Davis's research focuses on trauma surgery , acute care surgery , and domestic violence prevention , with over 150 PubMed publications. His work examines injury patterns, resuscitation metrics, and surgical outcomes while challenging conventional trauma paradigms like splenic preservation and vascular injury management. Recent studies analyze endovascular approaches, metabolic markers of shock, and firearm injury prevention strategies. His 2015-2022 publications highlight advancements in trauma laparotomy , critical care analgesia , and trauma systems optimization . Key collaborations include co-investigators Krista Kaups, John Bilello, and Amy Kwok across institutions like UCSD and Landstuhl Regional Medical Center. UCSF Fresno Faculty Research Award (1996) Henry J. Kaiser Teaching Award – Honorable Mention (1994) Senior Visiting Surgeon, American Association for the Surgery of Trauma (2011) As Region 9 Chief for the American College of Surgeons Committee on Trauma, Dr. Davis has standardized trauma care across five counties. He serves on the Journal of Trauma and Acute Care Surgery Editorial Board and the Western Trauma Association , shaping national guidelines for peripheral vascular injuries and penetrating neck trauma.